Lawrence Lamb

Company: IN8Bio

Job title: EVP, CSO & Co-Founder

Seminars:

Mastermind Session: So, We are in the Clinic…Now What? 4:00 pm

Reviewing the clinical data presented, and discussing the key progress and remaining areas of unmet need in clinical development Creating ‘next steps’ for the industry in development, from enhancing persistence and efficacy to developing combination trials Outlining combination options, how to choose them, and what mechanisms need to be addressed through combination therapy Discussing where…Read more

day: Day Two

Learning from Patient Selection, Biomarker Studies & Indications to Maximize Therapeutic Outcomes 2:15 pm

Discussing which patient populations respond, hypothesizing the mechanistic rationale for patient selection, and developing biomarkers for selection Outlining which indications are best suited to gamma delta therapy and understanding the mechanisms behind this Building clinical experience to deploy the right cells at the right time in the right indication, and gain the best patient outcomes…Read more

day: Day 2 pm track b

Panel Discussion: Sharing Perspectives on the Application & Attractiveness of Gamma Delta T Therapy in a Competitive Treatment Landscape 11:30 am

Discussing the pros and cons of gamma delta T therapies as a treatment option for patients vs. standard therapy and analogous immune cell therapies Communicating the key differentiators in the clinic that make gamma delta cells an attractive treatment option Outlining roadblocks to the uptake of gamma delta therapies in the clinic for developers to…Read more

day: Day 2 am track b

Industry Leader’s Fireside Chat 8:45 am

Contrasting therapeutic approaches to harness gamma delta T cells and provide an overview of the development landscape Identifying the greatest areas of opportunity and key challenges to the industry in gamma delta T cell development Discussing next steps in development, from combination approaches to gaining traction in the solid tumor spaceRead more

day: Day One